Tedoy, Axcel D.
HRN: 27-29-47 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/10/2025
06/16/2025
ORAL
4.5ml
Q8
Age
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes